Related references
Note: Only part of the references are listed.Structural insights into angiotensin receptor signaling modulation by balanced and biased agonists
Dongqi Zhang et al.
EMBO JOURNAL (2023)
Hidden allosteric sites and De-Novo drug design
Ashfaq Ur Rehman et al.
EXPERT OPINION ON DRUG DISCOVERY (2022)
Anti-AT1R autoantibodies and prediction of the severity of Covid-19
Franco Papola et al.
HUMAN IMMUNOLOGY (2022)
AT1 Receptors: Their Actions from Hypertension to Cognitive Impairment
Hanxue Wu et al.
CARDIOVASCULAR TOXICOLOGY (2022)
QR code model: a new possibility for GPCR phosphorylation recognition
Hao Chen et al.
CELL COMMUNICATION AND SIGNALING (2022)
Unmasking allosteric-binding sites: novel targets for GPCR drug discovery
Veronica Casado-Anguera et al.
EXPERT OPINION ON DRUG DISCOVERY (2022)
Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity
Otavio Cabral-Marques et al.
NATURE COMMUNICATIONS (2022)
Angiotensin and Endothelin Receptor Structures With Implications for Signaling Regulation and Pharmacological Targeting
David Speck et al.
FRONTIERS IN ENDOCRINOLOGY (2022)
Angiotensin System Autoantibodies Correlate With Routine Prognostic Indicators for COVID-19 Severity
Carmen M. Labandeira et al.
FRONTIERS IN MEDICINE (2022)
Conservation of Allosteric Ligand Binding Sites in G-Protein Coupled Receptors
Amanda E. Wakefield et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2022)
Insights into the Interaction of LVV-Hemorphin-7 with Angiotensin II Type 1 Receptor
Amanat Ali et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Dynamical Correlations Reveal Allosteric Sites in G Protein-Coupled Receptors
Pedro Renault et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Autoantibodies as Endogenous Modulators of GPCR Signaling
Meredith A. Skiba et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2021)
Cartilage oligomeric matrix protein is an endogenous beta-arrestin-2-selective allosteric modulator of AT1 receptor counteracting vascular injury
Yi Fu et al.
CELL RESEARCH (2021)
Allosteric coupling and biased agonism in G protein-coupled receptors
Andreas Bock et al.
FEBS JOURNAL (2021)
Pharmacology of Free Fatty Acid Receptors and Their Allosteric Modulators
Manuel Grundmann et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Allosteric Modulation of GPCRs of Class A by Cholesterol
Jan Jakubik et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Angiotensin II receptor I auto-antibodies following SARS-CoV-2 infection
Yonghou Jiang et al.
PLOS ONE (2021)
Allosteric ligands control the activation of a class C GPCR heterodimer by acting at the transmembrane interface
Lei Liu et al.
ELIFE (2021)
Biased Allosteric Modulators: New Frontiers in GPCR Drug Discovery
Lauren M. Slosky et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2021)
Structural insights into ligand recognition and activation of angiotensin receptors
Haitao Zhang et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2021)
Receptor-Receptor Interactions and Glial Cell Functions with a Special Focus on G Protein-Coupled Receptors
Diego Guidolin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Novel allosteric ligands of the angiotensin receptor AT1R as autoantibody blockers
Khuraijam Dhanachandra Singh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Molecular insights into ago-allosteric modulation of the human glucagon-like peptide-1 receptor
Zhaotong Cong et al.
NATURE COMMUNICATIONS (2021)
Activation pathway of a G protein-coupled receptor uncovers conformational intermediates as targets for allosteric drug design
Shaoyong Lu et al.
NATURE COMMUNICATIONS (2021)
Molecular mechanism of biased signaling in a prototypical G protein-coupled receptor
Carl-Mikael Suomivuori et al.
SCIENCE (2020)
Angiotensin and biased analogs induce structurally distinct active conformations within a GPCR
Laura M. Wingler et al.
SCIENCE (2020)
Constitutive activity of a G protein-coupled receptor, DRD1, contributes to human cerebral organoid formation
Qinying Wang et al.
STEM CELLS (2020)
Interplay Between Angiotensin II Type 1 Receptor and Thrombin Receptor Revealed by Bioluminescence Resonance Energy Transfer Assay
Isra Al Zamel et al.
FRONTIERS IN PHARMACOLOGY (2020)
β-Arrestin Biased AT1 Agonist TRVO27 Causes a Neonatal-Specific Sustained Positive Inotropic Effect Without Increasing Heart Rate
Toshihide Kashihara et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2020)
Small Molecule Allosteric Modulators of G-Protein-Coupled Receptors: Drug-Target Interactions
Shaoyong Lu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Allosteric Modulator Discovery: From Serendipity to Structure-Based Design
Shaoyong Lu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Limited AT1 Receptor Internalization Is a Novel Mechanism Underlying Sustained Vasoconstriction Induced by AT1 Receptor Autoantibody From Preeclampsia
Jingwei Bian et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
GPCR Signaling Regulation: The Role of GRKs and Arrestins
Vsevolod V. Gurevich et al.
FRONTIERS IN PHARMACOLOGY (2019)
Antibodies against Angiotensin II Type 1 and Endothelin A Receptors: Relevance and pathogenicity
Mary Carmelle Philogene et al.
HUMAN IMMUNOLOGY (2019)
Toward Understanding the Impact of Dimerization Interfaces in Angiotensin II Type 1 Receptor
Ismail Erol et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2019)
Positive Modulation of Angiotensin II Type 1 Receptor-Mediated Signaling by LVV-Hemorphin-7
Amanat Ali et al.
FRONTIERS IN PHARMACOLOGY (2019)
Distinctive Activation Mechanism for Angiotensin Receptor Revealed by a Synthetic Nanobody
Laura M. Wingler et al.
CELL (2019)
Beta-Arrestin1 Prevents Preeclampsia by Downregulation of Mechanosensitive AT1-B2 Receptor Heteromers
Ursula Quitterer et al.
CELL (2019)
Mechanism of Hormone Peptide Activation of a GPCR: Angiotensin II Activated State of AT(1)R Initiated by van der Waals Attraction
Khuraijam Dhanachandra Singh et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2019)
ANGIOTENSIN II SIGNAL TRANSDUCTION: AN UPDATE ON MECHANISMS OF PHYSIOLOGY AND PATHOPHYSIOLOGY
Steven J. Forrester et al.
PHYSIOLOGICAL REVIEWS (2018)
Dynamic tuneable G protein-coupled receptor monomer-dimer populations
Patricia M. Dijkman et al.
NATURE COMMUNICATIONS (2018)
Homocysteine directly interacts and activates the angiotensin II type I receptor to aggravate vascular injury
Tuoyi Li et al.
NATURE COMMUNICATIONS (2018)
Structural insights into G-protein-coupled receptor allostery
David M. Thal et al.
NATURE (2018)
Discovery and Validation of Agonistic Angiotensin Receptor Autoantibodies as Biomarkers of Adverse Outcomes
Peter M. Abadir et al.
CIRCULATION (2017)
Differential Contribution of Transmembrane Domains IV, V, VI, and VII to Human Angiotensin II Type 1 Receptor Homomer Formation
Brent M. Young et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Understanding the common themes and diverse roles of the second extracellular loop (ECL2) of the GPCR super-family
Michael J. Woolley et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2017)
Trends in GPCR drug discovery: new agents, targets and indications
Alexander S. Hauser et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
An update on the physiological and therapeutic relevance of GPCR oligomers
Batoul Farran
PHARMACOLOGICAL RESEARCH (2017)
Angiotensin II type 1/adenosine A2A receptor oligomers: a novel target for tardive dyskinesia
Paulo A. de Oliveira et al.
SCIENTIFIC REPORTS (2017)
Oligomerization of GPCRs involved in endocrine regulation
Gunnar Kleinau et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2016)
Exploring the mechanism of F282L mutation-caused constitutive activity of GPCR by a computational study
Nan Gao et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2016)
Attenuation of ligand-induced activation of angiotensin II type 1 receptor signaling by the type 2 receptor via protein kinase C
Takayuki Inuzuka et al.
SCIENTIFIC REPORTS (2016)
Mechanism of agonistic angiotensin II type I receptor autoantibody-amplified contractile response to Ang II in the isolated rat thoracic aorta
Wenhui Zhang et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2015)
Biased signalling: the instinctive skill of the cell in the selection of appropriate signalling pathways
Ying Liu et al.
BIOCHEMICAL JOURNAL (2015)
Dopamine D2 and angiotensin II type 1 receptors form functional heteromers in rat striatum
E. Martinez-Pinilla et al.
BIOCHEMICAL PHARMACOLOGY (2015)
Cardiac myosin light chain phosphorylation and inotropic effects of a biased ligand, TRV120023, in a dilated cardiomyopathy model
Madhusudhan Tarigopula et al.
CARDIOVASCULAR RESEARCH (2015)
Identification of Amino Acid Residues in Angiotensin II Type 1 Receptor Sensing Mechanical Stretch and Function in Cardiomyocyte Hypertrophy
Guoliang Jiang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
Dual agonist occupancy of AT1-R-α2C-AR heterodimers results in atypical Gs-PKA signaling
Morgane Bellot et al.
NATURE CHEMICAL BIOLOGY (2015)
Angiotensin II Type I and Prostaglandin F2α Receptors Cooperatively Modulate Signaling in Vascular Smooth Muscle Cells
Eugenie Goupil et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Structure and function of G protein-coupled receptor oligomers: implications for drug discovery
Nicole S. Schonenbach et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2015)
Autoantibodies Toward the Angiotensin 2 Type 1 Receptor: A Novel Autoantibody in Alzheimer's Disease
Lasse M. Giil et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Agonistic autoantibodies against the angiotensin AT1 receptor increase in unstable angina patients after stent implantation
Miao Tian et al.
CORONARY ARTERY DISEASE (2014)
Allosteric Modulation of β-Arrestin-biased Angiotensin II Type 1 Receptor Signaling by Membrane Stretch
Wei Tang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Allosteric and biased G protein-coupled receptor signaling regulation: potentials for new therapeutics
Etienne Khoury et al.
FRONTIERS IN ENDOCRINOLOGY (2014)
Higher Risk of Kidney Graft Failure in the Presence of Anti-Angiotensin II Type-1 Receptor Antibodies
M. Taniguchi et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
GPCR heterodimers: asymmetries in ligand binding and signalling output offer new targets for drug discovery
Eugenie Goupil et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
The apelin receptor inhibits the angiotensin II type 1 receptor via allosteric trans-inhibition
K. Siddiquee et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Endothelin-1, Oxidative Stress, and Endogenous Angiotensin II Mechanisms of Angiotensin II Type I Receptor Autoantibody-Enhanced Renal and Blood Pressure Response During Pregnancy
Justin Brewer et al.
HYPERTENSION (2013)
Structure of the Human Angiotensin II Type 1 (AT1) Receptor Bound to Angiotensin II from Multiple Chemoselective Photoprobe Contacts Reveals a Unique Peptide Binding Mode
Dany Fillion et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Emerging paradigms in GPCR allostery: implications for drug discovery
Denise Wootten et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Increased Susceptibility to Metabolic Syndrome in Adult Offspring of Angiotensin Type 1 Receptor Autoantibody-Positive Rats
Suli Zhang et al.
ANTIOXIDANTS & REDOX SIGNALING (2012)
Allosteric interactions within the AT1 angiotensin receptor homodimer: Role of the conserved DRY motif
Bence Szalai et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Biased signalling and allosteric machines: new vistas and challenges for drug discovery
Terry P. Kenakin
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Functionally Selective AT(1) Receptor Activation Reduces Ischemia Reperfusion Injury
Anders Hostrup et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2012)
Binding of Losartan to Angiotensin AT1 Receptors Increases Dopamine D1 Receptor Activation
Dong Li et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Cardiorenal Actions of TRV120027, a Novel β-Arrestin-Biased Ligand at the Angiotensin II Type I Receptor, in Healthy and Heart Failure Canines A Novel Therapeutic Strategy for Acute Heart Failure
Guido Boerrigter et al.
CIRCULATION-HEART FAILURE (2011)
Angiotensin II Type 1 Receptor Antibodies and Increased Angiotensin II Sensitivity in Pregnant Rats
Katrin Wenzel et al.
HYPERTENSION (2011)
Selectively Engaging β-Arrestins at the Angiotensin II Type 1 Receptor Reduces Blood Pressure and Increases Cardiac Performance
Jonathan D. Violin et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
G protein coupled receptors as allosteric proteins and the role of allosteric modulators
Terry Kenakin
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2010)
Biased Signaling of the Angiotensin II Type 1 Receptor Can Be Mediated through Distinct Mechanisms
Marie Mi Bonde et al.
PLOS ONE (2010)
Allostery at G Protein-Coupled Receptor Homo- and Heteromers: Uncharted Pharmacological Landscapes
Nicola J. Smith et al.
PHARMACOLOGICAL REVIEWS (2010)
β-Arrestin-Biased Agonism of the Angiotensin Receptor Induced by Mechanical Stress
Kriti Rakesh et al.
SCIENCE SIGNALING (2010)
Changes in angiotensin II type 1 receptor signalling pathways evoked by a monoclonal antibody raised to the N-terminus
Fang Xiao et al.
JOURNAL OF ENDOCRINOLOGY (2008)
β-arrestin-biased ligands at seven-transmembrane receptors
Jonathan D. Violin et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
β-arrestin2-mediated inotropic effects of the angiotensin II type 1A receptor in isolated cardiac myocytes
Keshava Rajagopal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor
E Kostenis et al.
CIRCULATION (2005)
Oligomerization of wild type and nonfunctional mutant angiotensin II type I receptors inhibits Gαq protein signaling but not ERK activation
JL Hansen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Dual inhibition of β-adrenergic and angiotensin II receptors by a single antagonist -: A functional role for receptor-receptor interaction in vivo
L Barki-Harrington et al.
CIRCULATION (2003)
Independent β-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2
HJ Wei et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Angiotensin receptors: form and function and distribution
WG Thomas et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2003)
Drugs targeting the renin-angiotensin-aldosterone system
MA Zaman et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
Side-chain substitutions within angiotensin II reveal different requirements for signaling, internalization, and phosphorylation of type 1A angiotensin receptors
AC Holloway et al.
MOLECULAR PHARMACOLOGY (2002)
The angiotensin II AT2 receptor is an AT1 receptor antagonist
S AbdAlla et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration
S AbdAlla et al.
NATURE (2000)
Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension
MLX Fu et al.
JOURNAL OF HYPERTENSION (2000)
Share Paper
